Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
Not Applicable
Completed
- Conditions
- Vitiligo
- Registration Number
- NCT03367273
- Lead Sponsor
- Cairo University
- Brief Summary
study \& verify the hypothesis of the involvement of TSLP in the pathogenesis of vitiligo in comparison to their levels in the healthy control persons.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
-
• Patients with generalized non-segmental vitiligo.
- Both sexes.
- Age < 18 years old age.
- New cases or cases not receiving any medication for at least 3 months ago.
Exclusion Criteria
-
• Age: Patients < 18 years.
- Segmental or universal vitiligo.
- Pregnant and lactating females. Autoimmune diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Expression levels of TSLP in patients of Vitiligo. 7 months
- Secondary Outcome Measures
Name Time Method